Gossamer Bio (GOSS) Net Shares Issued and Repurchased (2018 - 2020)
Gossamer Bio (GOSS) posted Net Shares Issued and Repurchased of $1.7 million for Q1 2020, down 58.87% on a QoQ basis from $4.2 million in Q4 2019, and down 27.82% year-over-year from $2.4 million in Q2 2019.
Analysis
Gossamer Bio (GOSS) Net Shares Issued and Repurchased (2018 - 2020) Analysis & Trends
Gossamer Bio has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $1.7 million in Q1 2020.
- On a quarterly basis, Net Shares Issued and Repurchased fell 27.82% year-over-year to $1.7 million in Q1 2020; TTM through Mar 2020 was $1.7 million, a 27.82% decrease from a year earlier, with the FY2019 full-year figure at $4.2 million, down 18.45% from the prior year.
- Net Shares Issued and Repurchased was $1.7 million for Q1 2020 at Gossamer Bio, down from $4.2 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $5.1 million in Q4 2018, with the low at $1.7 million in Q1 2020.
- Average Net Shares Issued and Repurchased over 3 years is $3.4 million, with a median of $3.3 million recorded in 2019.
- The sharpest annual moves came in 2019 and 2020: Net Shares Issued and Repurchased retreated 18.45% in 2019, then declined 27.82% in 2020.
- Over 3 years, Net Shares Issued and Repurchased stood at $5.1 million in 2018, then dropped by 18.45% to $4.2 million in 2019, then slumped by 58.87% to $1.7 million in 2020.
- The last three Net Shares Issued and Repurchased figures came in at $1.7 million (Q1 2020), $4.2 million (Q4 2019), and $2.4 million (Q1 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Gossamer Bio | 57.60 Mn | 576,568.19 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 1.73 Mn |
| Dec 31, 2019 | 4.19 Mn |
| Mar 31, 2019 | 2.39 Mn |
| Dec 31, 2018 | 5.14 Mn |